Thomas Ryder Booth, Chief Technology and Engineering Officer of Chevron Corp, filed a Form 4 on November 13, 2026, disclosing transactions in Chevron common stock and a non-qualified stock option dated November 11, 2026.
John Downing, EVP of Worldwide Sales Operations at NetScout Systems Inc, filed a Form 4 on November 13, 2026, disclosing the sale of 8,000 shares of common stock on November 10, 2026.
A Form 4 filed on November 13, 2026 discloses that John Vong, SVP - Accounting (PAO) at Astrana Health, Inc., surrendered 642 shares of common stock on November 12, 2026 to satisfy tax withholding obligations tied to vesting restricted stock.
Bob R. Simpson, a director and 10% owner of TXO Partners, L.P., filed a Form 4 on November 13, 2026, disclosing open-market purchases of Common Units on November 11 and November 12, 2026.
Ignacio J Walker, Chief Legal Officer of Bunge Global SA, filed an initial statement of beneficial ownership with the SEC on November 13, 2026, with a triggering event date of November 9, 2026.
Pacific Biosciences of California, Inc. received an initial beneficial ownership statement from William Meyer, its newly identified Chief Accounting Officer, filed on November 13, 2026 and reflecting a qualifying event date of November 3, 2026.
Jason J Price filed an initial statement of beneficial ownership with the SEC on November 13, 2026, disclosing no securities held in Barings Corporate Investors as of the event date of November 2, 2026.
Neil James Laverty, Chief Accounting Officer of Lucid Group, Inc. (NASDAQ:LCID), filed a Form 4 on November 13, 2026, disclosing the acquisition of restricted stock units and performance-based restricted stock units on November 10, 2026.
Michael James Tucker filed an initial statement of beneficial ownership with the SEC on November 13, 2026, disclosing his holdings in Churchill Downs Inc as of the event date of October 27, 2026, following his appointment as a director.
Nasdaq Stock Market LLC filed a notification of removal from listing and registration on November 13, 2026, covering HeartBeam, Inc.'s warrants under Section 12(b) of the Securities Exchange Act of 1934.